15.85 USD
↗ 0.03 (0.19%)AT CLOSE (03:59 PM EDT)
Personalis, Inc. Common Stock
PSNLNASDAQ • USD
15.60
↘ 0.25 (1.60%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
15.60
↘ 0.25 (1.60%)
Market: CLOSED
Shares of Personalis, Inc. Common Stock (PSNL) are trading at $15.85. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 23, 2026.
Open?$15.73
High?$15.89
Low?$15.67
Prev. Close?$15.82
Volume?1.1M
Avg. Volume?2.3M
VWAP?$15.85
Rel. Volume?0.48x
Bid / Ask
Bid?$12.91 × 100
Ask?$18.53 × 100
Spread?$5.62
Midpoint?$15.72
Valuation & Ratios
Market Cap?1.7B
Shares Out?104.7M
Float?67.3M
Float %?64.2%
P/E Ratio?N/A
P/B Ratio?7.20
EPS?-$1.00
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Themes
Employees
260
Market Cap
1.7B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2019-06-20
Address
6600 DUMBARTON CIRCLE
FREMONT, CA 94555
Phone: 650-752-1300
FREMONT, CA 94555
Phone: 650-752-1300
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?14
Short Sent.?40
Piotroski F-Score?0/9Weak
Altman Z-Score?17.57Safe
Confidence?51%Low
Short InterestHigh
Short % of Float?12.53%High
Short Interest?8.4M
Days to Cover?4.3
Free Float67.3M
Avg Daily Volume1.9M
Settlement Date2026-09-30
Financial Health
Current Ratio?5.28Strong
Quick Ratio?5.08Strong
Cash Ratio?2.03Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?7.20FAIR▾
Peers100
S&P26
P/S?24.30HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-15.3CHEAP▾
S&P97
EV/Sales?22.95HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-45.6%WEAK▾
S&P3
ROA?-34.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-100975000
Enterprise Value?$1.6B
Fundamentals ratios updated end of day